Nanalysis Scientific Corp.
NSCIF
$0.2215
$0.01175.58%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 74.28% | 48.88% | 36.03% | 26.98% | -148.10% |
| Total Depreciation and Amortization | -58.86% | -61.90% | -60.64% | 132.00% | 0.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -75.52% | -- |
| Total Other Non-Cash Items | -78.83% | 492.77% | 171.45% | 257.69% | 480.96% |
| Change in Net Operating Assets | -36.21% | 269.55% | 2,635.24% | 37.17% | 42.65% |
| Cash from Operations | 76.54% | 130.75% | 137.48% | 57.10% | 17.27% |
| Capital Expenditure | 2.22% | 99.55% | 87.72% | -167.11% | 99.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -103.52% | 100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.35% | 75.71% | 46.87% | -52.02% | 43.64% |
| Cash from Investing | 68.55% | 79.50% | 57.05% | -226.82% | 46.62% |
| Total Debt Issued | -56.91% | -- | -- | 5.34% | 2,832.98% |
| Total Debt Repaid | 69.30% | 73.91% | -895.97% | 82.65% | -702.26% |
| Issuance of Common Stock | -- | -100.00% | 17,328.00% | -100.00% | -- |
| Repurchase of Common Stock | -1,900.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.55% | -396.67% | -292.39% | -183.06% | -142.20% |
| Cash from Financing | 83.80% | -112.91% | -98.60% | 120.35% | -127.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.88% | -117.44% | 153.02% | 88.39% | 17.72% |